Document Detail

Auto-stimulatory action of secreted caveolin-1 on the proliferation of Ewing's sarcoma cells.
MedLine Citation:
PMID:  21373757     Owner:  NLM     Status:  MEDLINE    
Caveolin-1 (CAV1) is highly expressed in Ewing's sarcoma (EWS). We previously showed that increased cellular CAV1 is associated with the regulation of the tumorigenicity, drug resistance and metastatic ability of EWS cells. Because several studies reported that melanoma and prostate cancer cells, which express relatively high CAV1 levels, secrete CAV1, and that secreted CAV1 is associated with tumor progression, our study explored the possibility that EWS cells also secreted CAV1 and that secreted CAV1 may contribute to EWS pathobiology. Results from experiments involving the ectopic expression of a Myc-tagged CAV1 protein in EWS cells as well as the supplementation of culture media with purified CAV1 protein followed by its intracellular localization using immunofluorescence demonstrated that EWS cells secrete CAV1, that they are able to take up the secreted protein, and that extracellular CAV1 enhances EWS cell proliferation. These findings strongly support the notion that secreted CAV1 may also contribute to the malignant properties of EWS.
Aniruddha Sengupta; Silvia Mateo-Lozano; Oscar M Tirado; Vicente Notario
Related Documents :
17949107 - Separation of murine neutrophils and macrophages by thermoresponsive magnetic nanoparti...
19873357 - Pacemakers in nitella : iii. electrical alternans.
12565147 - Orientation of human glioblastoma cells embedded in type i collagen, caused by exposure...
21332337 - Expression of cd19(+)cd5(+)b cells and iga1-positive cells in tonsillar tissues of iga ...
21266077 - Microrna-34a is a potent tumor suppressor molecule in vivo in neuroblastoma.
22853627 - Comparison between stem cells harvested from wet and dry lipoaspirates.
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't     Date:  2011-03-03
Journal Detail:
Title:  International journal of oncology     Volume:  38     ISSN:  1791-2423     ISO Abbreviation:  Int. J. Oncol.     Publication Date:  2011 May 
Date Detail:
Created Date:  2011-03-22     Completed Date:  2011-08-03     Revised Date:  2014-09-13    
Medline Journal Info:
Nlm Unique ID:  9306042     Medline TA:  Int J Oncol     Country:  Greece    
Other Details:
Languages:  eng     Pagination:  1259-65     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Bone Neoplasms / metabolism,  pathology*
Caveolin 1 / secretion*
Cell Line, Tumor
Cell Proliferation / drug effects
Sarcoma, Ewing / metabolism,  pathology*,  secretion
Grant Support
P30-CA-CA51008/CA/NCI NIH HHS; R01 CA134727/CA/NCI NIH HHS; R01 CA134727-01/CA/NCI NIH HHS; R01 CA134727-02/CA/NCI NIH HHS; R01 CA134727-03/CA/NCI NIH HHS; R01 CA134727-04/CA/NCI NIH HHS; R01-CA134727/CA/NCI NIH HHS
Reg. No./Substance:
0/Caveolin 1

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Potent anti-tumor killing activity of the multifunctional Treg cell line HOZOT against human tumors ...
Next Document:  microRNA expression profiling of nasopharyngeal carcinoma.